Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
3.64
7.61
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Shandong Weigao Group Medical Polymer Co Ltd
Total Current Liabilities
Shandong Weigao Group Medical Polymer Co Ltd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Total Current Liabilities
ÂĄ6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
||
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
|
Total Current Liabilities
ÂĄ377.8m
|
CAGR 3-Years
70%
|
CAGR 5-Years
74%
|
CAGR 10-Years
N/A
|
||
Autobio Diagnostics Co Ltd
SSE:603658
|
Total Current Liabilities
ÂĄ2.2B
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
||
Winner Medical Co Ltd
SZSE:300888
|
Total Current Liabilities
ÂĄ4.3B
|
CAGR 3-Years
21%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
||
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Total Current Liabilities
ÂĄ591.5m
|
CAGR 3-Years
6%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
||
Intco Medical Technology Co Ltd
SZSE:300677
|
Total Current Liabilities
ÂĄ12.2B
|
CAGR 3-Years
77%
|
CAGR 5-Years
76%
|
CAGR 10-Years
N/A
|
Shandong Weigao Group Medical Polymer Co Ltd
Glance View
Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of medical devices. The company is headquartered in Weihai, Shandong. The company went IPO on 2004-02-27. The firm sells products under brand names of Jierui and Wego Ortho. The firm operates through three business segments. The Single Use Medical Device Products segment is engaged in the production and sale of single-use consumables, such as infusion sets, syringes, blood transfusion sets and blood bags. The Orthopaedic Products segment is engaged in the production and sale of orthopaedic products. The Blood Purification Products segment is engaged in the production and sale of blood purification products and related medical equipment. The firm is also engaged in the manufacture of industrial automatic equipment and parts, as well as the provision of logistics and storage services through its subsidiaries.
See Also
What is Shandong Weigao Group Medical Polymer Co Ltd's Total Current Liabilities?
Total Current Liabilities
6B
CNY
Based on the financial report for Jun 30, 2024, Shandong Weigao Group Medical Polymer Co Ltd's Total Current Liabilities amounts to 6B CNY.
What is Shandong Weigao Group Medical Polymer Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
9%
Over the last year, the Total Current Liabilities growth was -10%. The average annual Total Current Liabilities growth rates for Shandong Weigao Group Medical Polymer Co Ltd have been 2% over the past three years , 9% over the past five years .